Furthermore, resistin accelerates the EMT process in ovarian cancer cells by decreasing the expression of the epithelial cell marker E-cadherin and boosting the expression of the mesenchymal cell markers ZEB1 and Vimentin, thereby encouraging cancer cells to migrate [29,34]. This evidence concerns the gene CDH1 and ovarian carcinoma.